The Board of Directors of United Therapeutics Corporation has authorized a buyback plan on March 24, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
255.1 USD | +8.88% | +7.65% | +16.03% |
May. 01 | Transcript : United Therapeutics Corporation, Q1 2024 Earnings Call, May 01, 2024 | |
May. 01 | United Therapeutics Q1 Net Income, Revenue Advance; Shares Rise Pre-Bell | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.03% | 10.4B | |
+0.67% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+6.55% | 24.63B | |
-21.66% | 18.2B | |
+29.96% | 12.01B | |
-1.57% | 11.76B | |
-4.80% | 9.94B | |
-4.38% | 9.39B |
- Stock Market
- Equities
- UTHR Stock
- News United Therapeutics Corporation
- United Therapeutics Corporation authorizes a Buyback Plan.